Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Market Whispers
Tax Planning
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund

| More

Federal Bank - One-off slippage mars performance - Centrum

Posted On: 2013-01-21 19:50:42

FED's Q3FY13 core performance was largely in line (PPP at Rs3.9bn vs Rs3.8bn estimated) though spike in provisions led to a lower than expected bottomline. NIM contracted by ~10bps QoQ on reversal of interest income on NPAs. Asset quality matrices deteriorated due to one-offs with 1) gross slippage rate jumping to 5.4% led by chunky slippage 2) GNPA going up 9% QoQ to 3.85% and 3) PCR eroding by 600bps QoQ despite high provisioning cost at 82bps. Notwithstanding the one-off hit to asset quality during the quarter, we remain positive on the radical changes introduced by the new management and its potential long term benefits. We stick to our thesis of RoE expansion, which in turn should drive further re-rating of the stock over the long term. We maintain Buy and target price of Rs600.

- NIM contracts by 11bps QoQ: NII de-grew by 6% YoY to Rs5.0bn as NIM contracted by 11bps QoQ offsetting the uptick in credit growth (19% YoY vs 8% last quarter). Importantly, the contraction in NIM was the result of reversal of interest income on NPAs (Rs300mn mainly Air India & NAFED). Meanwhile, cost of deposits inched up marginally as the last leg of NR deposits repriced upwards to post-deregulation rates. Q4FY13 would still have the burden of Air India FITL and hence will continue to contain NIMs. Management guided for a NIM of 3.55% for FY13.

- Uptick in loan growth: Loan growth during the quarter registered an uptick and stood at 19% YoY (from 8% in the previous quarter) with key segments driving growth. The corporate segment made a major comeback with 12.6% QoQ growth. Incrementally, the bank remains comfortable in expanding its SME and retail book given acceptable slippage performance though cautious stance towards corporate segment will stay for the near term. The management intends to close FY13 with a loan growth of 15-16% while for FY14 it expects to get more aggressive with target of ~25% YoY.

- Slippage rate spikes to 5.4%: After a clear moderating trend for the last 4 quarters, slippage rate spiked to 5.4% led by chunky NPAs. Exposure to NAFED (Rs2bn) was recognized as NPA (40% provided for) and the borrower has requested for a settlement with 40% haircut. Various banks exposed to NAFED have declined to accept 40% haircut and hence negotiations are underway with resolution likely in a couple of quarters. The bank sold off Rs710mn worth of NPAs to ARCIL, net of which the slippage rate would have been 4.8%. Effectively, the %GNPA inched up by 10bps QoQ to 3.85% while pushing the PCR down by 600bps QoQ to 77%.

- Maintain Buy: The management's strategy to enhance RoE by optimally leveraging the equity, enhancing liability franchisee and containing asset stress is gradually yielding results (albeit mixed). We expect the aggressive branch expansion to start yielding results over FY14 & FY15 in terms of growth and enhanced liability profile. At the current price, the stock is trading at 1.3x FY14E ABV and implies 19% upside to our price target of Rs600. We suggest investors should Buy the stock.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

TCS (TCS IN) - Revenue growth way below street expectation - Cholamandalam Securities
Infosys (INFO IN) - Result in-line with street expectation; guidance disappoints - Cholamandalam Securities
BUY Dishman Pharma - Better traction expected from CRAMS and disinfectants: AnandRathi Institutional Research
Neutral on ICICI Prudential Life Insurance Co. Ltd. IPO - Angel Broking
ICICI Prudential Life Insurance Company Ltd - IPO Note - Religare
ICICI Prudential Life Insurance Co. Ltd. - Pure play on life insurance - Geojit BNP Paribas
Fiberweb India Ltd - Set to grow at a rapid pace; initiate with BUY - BOB Capital Markets Ltd
BUY Bajaj Electricals - Growth momentum in all divisions expected in 2HFY17: AnandRathi Institutional Equity
Majesco Ltd - Well-placed to Leverage Conducive Industry Tailwinds - Reliance Securities
HCL Technologies - Event Update - Automation Focus a Key Differentiator - Reliance Securities
Aurobindo Pharma - 1QFY2017 Result Update - Angel Broking
HOLD India Cements - Subdued quarter; prices to recover: AnandRathi Institutional Research
Cement - 1QFY17 Results Review - Robust performance continues on cost benefits - Reliance Securities
NTPC 1QFY17: Result Review - In line with our expectations - Maintain BUY - Reliance Securities
KNR Constructions - 1QFY2017 Result Update - Angel Broking
BUY NRB Bearings - Margin expansion in Q1 leads to robust profitability: AnandRathi Institutional Reserach
BUY AIA Engineering - Margins likely to hold: AnandRathi Institutional Reserach
BUY Vivimed Labs - Better pharma growth, lower interest cost drive earning - Anand Rathi
Radico Khaitan - 1QFY2017 Result Update - Angel Broking
BUY KNR Constructions - Strong beginning, move toward a high-growth trajectory; AnandRathi Institutional Research
Dishman Pharmaceuticals - 1QFY2017 Result Update - Angel Broking
BUY Ahluwalia Contracts India - Steady growth intact: AnandRathi Institutional Research
BUY JK Lakshmi Cement - Strong start; growth set to endure: AnandRathi Institutional Research
Ahluwalia Contracts India Ltd - 1QFY17 Result Update - BUY - Healthy Performance Continues - Reliance Securities
Sun Pharmaceuticals - 1QFY2017 Result Update - Angel Broking
BUY MRF - Outstripping yet again: Anand Rathi Institutional Research
Bajaj Electricals - 1QFY2017 Result Update - Angel Broking
Lupin - 1QFY2017 Result Update - Angel Broking
Cadila Healthcare - 1QFY2017 Result Update - Angel Broking
BUY Jyothy Laboratories - With multiple triggers, outlook 'bright': Anand Rathi Institutional Research
IPCA Laboratories - 1QFY2017 Result Update - Angel Broking
Cipla - 1QFY2017 Result Update - Angel Broking
HCL Technologies - 1QFY2017 Result Update - Angel Broking
Tech Mahindra - 1QFY2017 Result Update - Angel Broking
Linc Pen & Plastics - 1QFY2017 Result Update - Angel Broking
Garware Wall Ropes - 1QFY2017 Result Update - Angel Broking
Union Bank of India - 1QFY17 Result Update - Better show on operating front, asset quality remains weak - Reliance Securities
Colgate Palmolive (India) - 1QFY17 Result Update - Volumes Recover but at a Cost - Reliance Securities
Views on Lupin Limited 1QFY2017 Results: Angel Broking
BUY Mangalam Cement - Stellar operational performance; AnandRathi Institutional Research
BUY Majesco - Soft quarter, profitability improving: AnandRathi Institutional Research
Views on Bank of Baroda 1QFY2017 Results: Angel Broking
BUY Aegis Logistics - Strong throughput volumes, H2 to be better: AnandRathi Institutional Research
Views on Ipca Laboratories Ltd 1QFY2017 Results: Angel Broking
Views on State Bank of India 1QFY2017 Results: Angel Broking
Views on Sun Pharmaceutical Industries Limited 1QFY2017 Results: Angel Broking
Shree Cement: 1QFY17 Result: FIRST CUT - Reliance Securities
Views on Cipla Ltd 1QFY2017 Results: Angel Broking
Views on Union Bank of India 1QFY2017 Results: Angel Broking
United Phosphorus - 1QFY2017 Result Update - Angel Broking

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2016